← Back to Search

Treatment for Biliary Atresia (BASIC Trial)

N/A
Recruiting
Led By Lisa Henn, PhD
Research Sponsored by Arbor Research Collaborative for Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up observational information collected at entrance into study as well as at each yearly follow-up visit.
Awards & highlights

Summary

Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To identify polymorphisms that may be important in disease progression such as HLA polymorphisms; To characterize the natural history of the older, non-transplanted child with BA.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~observational information collected at entrance into study as well as at each yearly follow-up visit.
This trial's timeline: 3 weeks for screening, Varies for treatment, and observational information collected at entrance into study as well as at each yearly follow-up visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To identify the gene or genes implicated in the etiology of BA
Secondary outcome measures
Define the natural history of the older, non-transplanted child with biliary atresia

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,410 Previous Clinical Trials
4,323,626 Total Patients Enrolled
5 Trials studying Biliary Atresia
2,823 Patients Enrolled for Biliary Atresia
Arbor Research Collaborative for HealthLead Sponsor
20 Previous Clinical Trials
34,202 Total Patients Enrolled
2 Trials studying Biliary Atresia
1,552 Patients Enrolled for Biliary Atresia
Lisa Henn, PhDPrincipal InvestigatorArbor Research Collaborative for Health - Data Coordinating Center
6 Previous Clinical Trials
6,524 Total Patients Enrolled
2 Trials studying Biliary Atresia
1,552 Patients Enrolled for Biliary Atresia
~253 spots leftby May 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top